Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study
- PMID: 15758763
- DOI: 10.1097/01.ju.0000159198.83103.01
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study
Abstract
Purpose: We evaluated the efficacy and tolerability of pentosan polysulfate sodium (PPS) for the treatment of men with chronic pelvic pain syndrome (CPPS), National Institutes of Health (NIH) category III.
Materials and methods: In a 16-week double-blind study 100 men with a clinical diagnosis of CPPS were randomized to receive 300 mg PPS or placebo 3 times daily. Clinical Global Improvement (CGI) was the primary outcome measure. Additional outcome measures were the NIH-Chronic Prostatitis Symptom Index (CPSI), Subjective Global Assessment and Symptom Severity Index assessment tools.
Results: Significantly more patients receiving PPS experienced moderate to marked improvement based on CGI assessment (18 or 37% vs 8 or 18%, p = 0.04). However, mean CGI scores were not significantly different between the PPS group (1.0) and placebo groups (1.0 vs 0.6, p = 0.107). All NIH-CPSI domains suggested a positive effect for PPS and for total NIH-CPSI the difference approached statistical significance (-5.9 or 22% vs -3.2 or 12%, p = 0.068). The PPS group showed significantly greater improvement in NIH-CPSI quality of life domain scores than the placebo group (-2.0 or 22% vs -1.0 or 12%, p = 0.031). Of patients receiving PPS 67% and 80% of those receiving placebo completed the 16-week study. Diarrhea, nausea and headache were the most common adverse events.
Conclusions: Pentosan polysulfate (900 mg daily) was more likely than placebo to provide relief for CPPS symptoms.
Similar articles
-
Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.Urology. 2000 Sep 1;56(3):413-7. doi: 10.1016/s0090-4295(00)00685-3. Urology. 2000. PMID: 10962305 Clinical Trial.
-
A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.J Urol. 2003 Apr;169(4):1401-5. doi: 10.1097/01.ju.0000054983.45096.16. J Urol. 2003. PMID: 12629372 Clinical Trial.
-
Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.J Urol. 2004 Apr;171(4):1594-7. doi: 10.1097/01.ju.0000117811.40279.19. J Urol. 2004. PMID: 15017228 Clinical Trial.
-
Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.Expert Opin Pharmacother. 2010 Jun;11(8):1255-61. doi: 10.1517/14656561003709748. Expert Opin Pharmacother. 2010. PMID: 20429665 Review.
-
α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.BJU Int. 2012 Oct;110(7):1014-22. doi: 10.1111/j.1464-410X.2012.11088.x. Epub 2012 Apr 3. BJU Int. 2012. PMID: 22471591 Review.
Cited by
-
Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis/bladder pain syndrome: A pilot study.Curr Urol. 2024 Mar;18(1):49-54. doi: 10.1097/CU9.0000000000000156. Epub 2022 Oct 19. Curr Urol. 2024. PMID: 38505153 Free PMC article.
-
Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues.Pharmaceuticals (Basel). 2023 Mar 13;16(3):437. doi: 10.3390/ph16030437. Pharmaceuticals (Basel). 2023. PMID: 36986536 Free PMC article. Review.
-
Oral pharmacological treatments for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials.EClinicalMedicine. 2022 May 20;48:101457. doi: 10.1016/j.eclinm.2022.101457. eCollection 2022 Jun. EClinicalMedicine. 2022. PMID: 35706494 Free PMC article.
-
Diagnostic and Management Strategies for Patients with Chronic Prostatitis and Chronic Pelvic Pain Syndrome.Drugs Aging. 2021 Oct;38(10):845-886. doi: 10.1007/s40266-021-00890-2. Epub 2021 Sep 29. Drugs Aging. 2021. PMID: 34586623 Review.
-
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2019 Oct 6;10(10):CD012552. doi: 10.1002/14651858.CD012552.pub2. Cochrane Database Syst Rev. 2019. PMID: 31587256 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical